Trial Profile
Dual Trigger With GnRH Agonist and Human Chorionic Gonadotropin for Final Oocyte Maturation in Patients at High Risk of Ovarian Hyperstimulation Syndrome in GnRH Antagonist Protocol
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Chorionic gonadotropin (Primary) ; Triptorelin (Primary)
- Indications Female infertility; Ovarian hyperstimulation syndrome
- Focus Therapeutic Use
- 13 Jan 2014 New trial record